Mainz recruits first patient into biomarker research
ColoAlert research could identify advanced adenomas among colorectal cancer patients
Read More
Tag: biomarker
Research positions Nordic Bioscience’s PRO-C6 as next-generation biomarker
The PRO-C6 biomarker assay has been transferred to Roche Diagnostics for further analysis
Read More
Roche launches HER2 biomarker test for breast and gastric cancer
The test “advances Roche’s commitment to personalised healthcare”.
Read More
UCL researchers identify Huntington’s disease biomarker
Research led by scientists at UCL have identified the first blood test able to predict the onset and progression of Huntington’s disease (HD).
Read More
US approves Keytruda for MSI-H tumours
The US Food and Drug Administration has cleared use of Merck & Co’s immunotherapy Keytruda to treat cancer patients identified as having a biomarker called microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR).
Read More
- R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia
- Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million
- Nouscom to present re‑treatment data in Lynch Syndrome at ESMO 2026
- ViiV Healthcare to unveil new HIV treatment data at AIDS 2026
- Jasper Therapeutics merges with Kira Pharmaceuticals
